Clinical Trial Detail

NCT ID NCT02605044
Title Study to Compare the Efficacy and Safety of Masitinib in Combination With FOLFIRI to Placebo in Combination With FOLFIRI in Second Line Treatment of Patients With Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors AB Science
Indications

colorectal cancer

Therapies

Masitinib

Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult

No variant requirements are available.